The state-run company Saidal should see an increase in business volume in 2024, and plans are in place for an even bigger leap in 2025 through portfolio diversification as part of a strategy geared at reducing medication imports to the Arab country.
LATEST NEWS
- Al Jabal Al Akhdar named GCC Tourism Capital
- Syrian doctor’s stories at Brazil’s Book Biennial
- Real Madrid launches football program in Tunisia
- AIM: Arab Chamber calls for more digitalized trade
- Halal market continues to show its strength
- Syria opens tender for power equipment
- Qatar advances in education, OECD finds
- A Brazilian tax expert in Dubai
